vimarsana.com

Latest Breaking News On - Simcere pharmaceutical group ltd - Page 1 : vimarsana.com

Vivoryon Therapeutics N V Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date .

Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA

Simcere Pharmaceutical Group Limited Announces Findings of A Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in Jama

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.